Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Total 13F shares
-
15,337,936
-
Share change
-
+15,328,536
-
Total reported value
-
$730,185,000
-
Price per share
-
$48.89
-
Number of holders
-
76
-
Value change
-
+$729,725,256
-
Number of buys
-
75
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2014
As of 31 Mar 2014,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,337,936 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., Capital Research Global Investors, ADAGE CAPITAL PARTNERS GP LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT CO LLP, Visium Asset Management, LP, Capital World Investors, JENNISON ASSOCIATES LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.